P R Clemens|F J Duncan - JoVE Visualize

Showing results (1-10 of 36) with videos related to

Pageof 4

Sort By:

Current Neurology and Neuroscience Reports|March 20, 2002

Progress in gene therapy for Duchenne muscular dystrophyP R Clemens, F J Duncan

European Neurology|January 1, 1994

Gene therapy prospects for Duchenne muscular dystrophyP R Clemens, C T Caskey

Current Opinion in Rheumatology|November 1, 1996

HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathiesE P Hoffman, P R Clemens

Annals of Neurology|October 1, 1990

Adult phosphorylase b kinase deficiencyP R Clemens, M Yamamoto, A G Engel

Neurology|November 1, 1991

Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patientsM Yamamoto, P R Clemens, A G Engel

Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2001

Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNAF Liu, M Nishikawa, P R Clemens, et al.

Gene Therapy|May 29, 2009

Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disordersB M Koppanati, J Li, X Xiao, et al.

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 27, 1993

Gene transfer therapy for heritable disease: cell and expression targetingK Mitani, P R Clemens, A B Moseley, et al.

Human Molecular Genetics|November 1, 1994

Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunitM Wehner, P R Clemens, A G Engel, et al.

Gene Therapy|July 23, 2004

CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscleZ Jiang, G Schiedner, S C Gilchrist, et al.

Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:

Pageof 4

Current Neurology and Neuroscience Reports|March 20, 2002

Progress in gene therapy for Duchenne muscular dystrophyP R Clemens, F J Duncan

European Neurology|January 1, 1994

Gene therapy prospects for Duchenne muscular dystrophyP R Clemens, C T Caskey

Current Opinion in Rheumatology|November 1, 1996

HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathiesE P Hoffman, P R Clemens

Annals of Neurology|October 1, 1990

Adult phosphorylase b kinase deficiencyP R Clemens, M Yamamoto, A G Engel

Neurology|November 1, 1991

Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patientsM Yamamoto, P R Clemens, A G Engel

Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2001

Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNAF Liu, M Nishikawa, P R Clemens, et al.

Gene Therapy|May 29, 2009

Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disordersB M Koppanati, J Li, X Xiao, et al.

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 27, 1993

Gene transfer therapy for heritable disease: cell and expression targetingK Mitani, P R Clemens, A B Moseley, et al.

Human Molecular Genetics|November 1, 1994

Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunitM Wehner, P R Clemens, A G Engel, et al.

Gene Therapy|July 23, 2004

CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscleZ Jiang, G Schiedner, S C Gilchrist, et al.

Pageof 4